Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Octane BioTx is a regenerative medicine company focused on the development of advanced bioreactor systems and cell therapy products. The company is best known for its Cocoon platform, an automated, closed system for the manufacturing of personalized cell therapies, which was significantly advanced through a partnership and eventual technology transfer to Lonza. Octane BioTx continues to leverage its expertise in tissue engineering and automated bioprocessing to develop clinical-stage products for orthopedic and spinal applications. Their business model integrates proprietary automated manufacturing technology with biological products to streamline the delivery of regenerative treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Octane BioTx.